Applied Genetic Technologies Corporation (AGTC) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket
 


Applied Genetic Technologies Corporation  (NASDAQ: AGTC)


Applied Genetic Technologies's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Applied Genetic Technologies's ROI in the first quarter of 2023?
Applied Genetic Technologies Corporation recorded a cumulative net loss of $-70 million during 12 months ending in the first quarter of 2023, resulting in a negative return on investment (ROI) of -139.18%.

Within the Healthcare sector 974 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2022 from 0 to 5055.

Definition and Formula of Return on Investment



Return On Investment (Sep 30 2022)
I. Quarter
(Jun 30 2022)
IV. Quarter
(Mar 31 2022)
III. Quarter
(Dec 31 2021)
II. Quarter
(Sep 30 2021)
I. Quarter
Y / Y Investment Change TTM -44.97 % -25.91 % -1.57 % 22.02 % 15.04 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 31 41 61 68 89
Return On Investment (TTM) -139.18 % -106.14 % -77.02 % -67.05 % -64.96 %
AGTC's Overall Ranking # 5055 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -22.31 % -20.2 % -13.71 % 2.87 % 4.59 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -70 -69 -63 -63 -60




Return On Investment AGTC's Ranking
Within: No.
Industry # 153
Sector # 975
Overall # 5055

Return On Investment Statistics
High Average Low
8.67 %
-34.09 %
-139.18 %
(Sep 30 2016)   (Sep 30 2022)







Financial Statements
Applied Genetic Technologies's I. Quarter Investments $ 31 Millions AGTC's Balance sheet
Applied Genetic Technologies's I. Quarter Income $ -18 Millions Quarterly AGTC's Income Statement
AGTC's Income by Division See AGTC's Income by Division


AGTC Annual Return On Investment (Jun 30 2022)
2022
(Jun 30 2021)
2021
(Jun 30 2020)
2020
(Jun 30 2019)
2019
(Jun 30 2018)
2018
Total Investments in Millions 41 107 87 83 104
Y / Y Investment Growth -61.33 % 22.78 % 5.42 % -20.43 % -13.05 %
Net Income in Millions -69 -58 -46 -2 -21
Y / Y Net Income Growth - - - - -
Annual Return On Investment -166.22 % -53.92 % -52.53 % -2.42 % -20.45 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AGTC's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AGTC's Competitors
Subscribers only: Roi for Applied Genetic Technologies's Suppliers
Subscribers only: Return On Investment for AGTC's Customers

Other Ratios
AGTC's Roa AGTC's Inventory Turnover Ratio AGTC's Growth Rates AGTC's Dividend Statistics
AGTC's Profitability Ratios AGTC's Asset Turnover Ratio AGTC's Dividend Growth
AGTC's Roe AGTC's Valuation Ratios AGTC's Financial Strength Ratios AGTC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI


Date modified: 2026-09-08T15:10:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.